DrFirst and PatchRx Partnership Combines Medication History with Daily Patient Adherence Data

https://www.prnewswire.com/news-releases/drfirst-and-patchrx-partnership-combines-medication-history-with-daily-patient-adherence-data-302124060.html?tc=eml_cleartime

Community Health Network Selects Biofourmis to Help Drive Care-at-Home Outcomes Across the Continuum

https://www.prnewswire.com/news-releases/community-health-network-selects-biofourmis-to-help-drive-care-at-home-outcomes-across-the-continuum-302124335.html?tc=eml_cleartime

CG LIFE SPECIALTY AGENCY THE MARKET ELEMENT RELAUNCHES AS ELEMENT CG

This brand relaunch emphasizes a focus on building emerging life science and biopharma brands with complementary client offerings as part of the larger CG Life platform.

Cyclo Therapeutics, Inc. Announced the Start of its Phase 2b Study for Trappsol Cyclo to Treat Alzheimer's Disease, Aiming to Reduce Amyloid Beta and Tau

Scientists are always looking for ways to develop better medications or other therapies that can help slow down the progression of the disease or improve symptoms. This might involve testing new drugs in the lab or in clinical trials with people who have Alzheimer's.

Alfa Cytology Launches Full-Scale Research Services for Pancreatic Cancer to Achieve Preclinical Safety Assessment

Alfa Cytology has announced its pancreatic cancer research services for anticancer therapy in early preclinical stages.

Alfa Cytology Introduces Molecular Biology Services for TME Research

Alfa Cytology has announced its molecular biology services for TME research.

CordenPharma & GENEPEP Celebrate Strong Collaboration Leveraging Peptide Drug Substance Discovery & Clinical Development Expertise

ProPharma Is Now Certified as Medidata Rave EDC Accredited Partner

ProPharma, the world’s largest Research Consulting Organization (RCO), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, has announced that it received accreditation as a CRO partner for Medidata Rave EDC. This milestone marks a significant enhancement in ProPharma's service offering and ability to develop robust, custom electronic data collection systems for clinical research studies.

DrFirst Acquires Myndshft Technologies to Revolutionize Medication Management by Addressing Both Pharmacy and Medical Benefits

https://www.prnewswire.com/news-releases/drfirst-acquires-myndshft-technologies-to-revolutionize-medication-management-by-addressing-both-pharmacy-and-medical-benefits-302120178.html?tc=eml_cleartime

ReadyGo Diagnostics initiates volume manufacturing of its sample collection and preparation device with Porex

ReadyGo Diagnostics partners with Porex to scale up production of innovative Sampler, with applications in human and veterinary diagnostics, drug testing, and forensics.

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

Cotiviti Wins Stevie® Award for Sales & Customer Service

X-Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy

Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy

Drug discovery specialists Cresset have announced a major new hire in their senior leadership team with the appointment of Dr. Mutlu Dogruel as Vice President of AI Solutions

Amerigo Scientific Supplies Environmental Sampling Bootie for Salmonella and Environment Monitoring

Watson-Marlow Fluid Technology Solutions launches WMArchitect single-use solutions to optimise biopharmaceutical fluid management

Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitectTM single-use solutions to offer a wide range of biopharmaceutical fluid management innovations from a single, secure supplier.

Ace Neuroscience Unveils Integrated Drug Development Services for Stroke

Ace Neuroscience announces the launch of its integrated drug development services specifically designed for preclinical research on stroke.

CD BioSciences Announces Peptidomimetic Drug Screening Service to Accelerate Modern Drug Discovery

Rapid increase in purchasing teams expected at CPHI North America

SaniSure accelerates drug speed to market with Fill4Sure launch

I am writing to you with some exciting news from Sanisure, who has announced the launch of Fill4Sure™, a custom single-use filling assembly designed to expedite drugs to the market. Fill4Sure™ provides a cost-efficient solution to the critical challenges drug manufacturers experience throughout the fill-finish process. It offers tailor-made assemblies and allows for effortless scaling up or down to meet the varying needs across the industry. Here are some key features and benefits of Fill4Sure™: Extremely clean, low-particulate 2D surge bags Silicone over-molding for enhanced durability High-performance tubing for accuracy Oil and adhesive-free OEM and custom-designed needles These features streamline biomanufacturing or bioprocessing processes, helping manufacturers expand their capacity and secure supply chains. For more details, please refer to the full release below. Thanks, Char Winspear